LumiraDx (LumiraDx) Other Gross PPE : $52.0 Mil (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is LumiraDx Other Gross PPE?

LumiraDx's Other Gross PPE for the quarter that ended in Jun. 2023 was $52.0 Mil.

LumiraDx's quarterly Other Gross PPE increased from Dec. 2022 ($52.7 Mil) to Mar. 2023 ($125.1 Mil) but then declined from Mar. 2023 ($125.1 Mil) to Jun. 2023 ($52.0 Mil).

LumiraDx's annual Other Gross PPE increased from Dec. 2020 ($10.4 Mil) to Dec. 2021 ($27.7 Mil) and increased from Dec. 2021 ($27.7 Mil) to Dec. 2022 ($52.7 Mil).

LumiraDx Other Gross PPE Historical Data

The historical data trend for LumiraDx's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LumiraDx Other Gross PPE Chart

LumiraDx Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Other Gross PPE

10.39

27.75

52.68

LumiraDx Quarterly Data
	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Other Gross PPE	Get a 7-Day Free Trial								26.90	175.71	52.68	125.13	52.04

LumiraDx Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

LumiraDx (LumiraDx) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » LumiraDx Ltd (OTCPK:LMDXF) » Definitions » Other Gross PPE

Comparable Companies

Traded in Other Exchanges

N/A

Address

C/o Ocorian Trust (Cayman) Ltd, Windward 3, P.O. Box 1350, Regatta Office Park, Grand Cayman, CYM, KY1-1108

Website

https://www.lumiradx.com

LumiraDx Ltd is a next-generation point of care diagnostics company. It manufactures and commercializes an innovative diagnostic Platform that supports a broad menu of tests with lab comparable performance at the point of care. Geographical presence in United States, Italy, UK, Germany, Colombia, Sweden and Other countries. Majority revenue derives from U.S.